greeksoup/ stock research
Stock research / United States / RIGL / Planned sales

Rigel Pharmaceuticals Inc. planned insider sales

In the last twelve months insiders at Rigel Pharmaceuticals Inc. filed 3 Form 144 notices of planned sales, 9,000 shares worth $305,865 at the time of filing, from 2 sellers. The latest, filed 22 June 2026: Ali-Jackson Kamil (director), 2,500 shares worth $87,500, planned for around 22 June 2026 through Fidelity Brokerage Services LLC.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
22 June 2026Ali-Jackson KamilDirector2,500$87,50022 June 20262,500 shares from 22 June 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
26 May 2026Ali-Jackson KamilDirector2,500$72,92526 May 20262,500 shares from 26 May 2026Fidelity Brokerage Services LLCRestricted Stock VestingForm 144
20 February 2026Moos Walter HDirector4,000$145,44020 February 20264,000 shares from 20 February 2026Fidelity Brokerage Services LLCOption Granted 05/11/2016Form 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?